Kent W. Mouw, MD, PhD

I am a radiation oncology physician-scientist working at the interface of DNA repair biology, translational genomics, and clinical trials. I oversee a basic and translational research lab aimed at understanding the impact of tumor DNA repair pathway alterations on treatment response, with the ultimate goal of identifying predictive biomarkers that can help guide therapy decisions. I participate in biomarker-driven clinical trial design and genomic analysis of clinical trial specimens, particularly for bladder and prostate cancer. I am also a practicing radiation oncologist and treat patients with tumors of the genitourinary system, including prostate, bladder, and testicular cancers.